ICMR funded project"Chronic Kidney Disease and Associated Risk Factors among Auto-Rickshaw/Taxi Drivers from Delhi NCR– Emphasis on Air Pollution"

Major projects-1. ICMR research project entitled “To develop a short scale for ascertaining cause of death due to renal failure and to validate the scale in a prospective study design”.2. “A Phase 3, Multicenter, Multi-country, Open-label, Randomized, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of Desidustat Versus Darbepoetin for the Treatment of Anemia in Patients with Chronic Kidney Disease (CKD) who are not on Dialysis.” (CADILA)

Major projects-1. ICMR research project entitled “Medication Knowledge and Adherence Among Patients undergoing Hemodialysis and Effect of Educational Counselling”. 2. International Society of Nephrology initiative "Global Assessment of Acute Kidney Injury Incidence and outcomes: 0By25 Global snapshot. 3. A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of LNP1892 (Monotherapy) in CKD Patients with Secondary Hyperparathyroidism (SHPT), On Dialysis and Not on Dialysis. LUPIN 4. A randomized, double-blind, placebo-controlled, event driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP. NOVARTIS 5. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in CKD Patients not on Dialysis. AstraZeneca 6. A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients. AstraZeneca.

Major projects-1. UGC major research project entitled “Genetic Heterogeneity among Hypertensive patients with and without CKD”.2. IHRS Registry of Atrial Fibrillation; patient characteristics and clinical management.3. A Randomized, Open label, Prospective, Two arm, Comparative Multicentric study to Evaluate the Efficacy and Safety of fixed dose combination of cefpodoxime 200 mg + clavulanic acid 125 mg v/s cefpodoxime 200 mg in treatment of patients with acute bacterial sinusitis (Reliance)

Major project"A phase III, Randomized, Comparative, Open label study of IV Iron Isomaltoside 1000(Monomer) administered by Infusion or Repeated Bolus Injection in comparison with Oral Iron Sulphate in subject with Non Dialysis Dependent Chronic Kidney Disease and with Renal Related Anaemia. Sponsor Pharmacosmos"

1. Role of Azithromycin as an anti-inflammatory in Clinical Influenza – Randomized, double-blind, placebo controlled clinical trial”. (M Pharm dissertation work)